Akos Antwi
Psychiatric/Mental Health · Providence, RINPI 1760966436
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,055 of the $6,498 with a category attached, or 77.8%. 16 manufacturers reported payments, led by Neuronetics, Inc. at 39.3% of the total. Reporting peaked in 2024 at $2,364 and has fallen 82.2% since, to $421 in 2025. Among psychiatric/mental health clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 208 payments — averaging $31.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$3K
- AbbVie$2K
- Johnson & Johnson$329
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$323
- Otsuka America Pharmaceutical, Inc.$317
- Vanda Pharmaceuticals Inc.$231
- plus $866 from 10 others
What the payments were for
- Travel & lodging$1,39621%
- Food & beverage$5,05578%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 10 | $2,554 |
| AbbVie | 111 | $1,877 |
| Johnson & Johnson | 9 | $329 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $323 |
| Otsuka America Pharmaceutical, Inc. | 14 | $317 |
| Vanda Pharmaceuticals Inc. | 6 | $231 |
| Supernus Pharmaceuticals, Inc. | 6 | $198 |
| Lundbeck LLC | 8 | $175 |
| Neurocrine Biosciences, Inc. | 6 | $152 |
| Sunovion Pharmaceuticals Inc. | 8 | $141 |
| Neos Therapeutics, LP | 2 | $41 |
| Almatica Pharma LLC | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Bausch Health US, LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$2,052
- NEUROSTAR TMS THERAPY$206
- SPRAVATO$129
- Fanapt$125
- QELBREE$112
- VRAYLAR$102
How this compares
$6,498 in reported general payments places this provider in the 90th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Other psychiatric/mental health in Providence
- Donna McDonaldProvidence$9K
- Corey PotterProvidence$6K
- Nicole FlanaganProvidence$4K
- Melanie KoehlerProvidence$3K
- Adebola AdelaiyeProvidence$3K
- Katherine BlissProvidence$2K
- Irene LangProvidence$2K
- Olivia FooterProvidence$2K
- Molly MoranProvidence$2K
- Florette Fils-AimaProvidence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.